On Nov. 1, 2012, following Abiomed’s disclosure of the DOJ investigation, the company’s stock price fell by more than 30 percent, closing at $6.21.

Investors who purchased Abiomed stock prior to the company’s disclosure are encouraged to contact Hagens Berman to discuss legal representation. Investors can contact Mr. Kathrein by calling 510-725-3030 or by emailing ABMD@Hbsslaw.com.

More information about this investigation is available at http://hb-securities.com/investigations/Abiomed.

About Hagens Berman

Hagens Berman Sobol Shapiro LLP is an investor-rights class-action law firm with offices in 10 cities. The firm represents whistleblowers, workers and consumers in complex litigation. More about the law firm and its successes can be found at www.hbsslaw.com. The firm’s securities law blog is at www.meaningfuldisclosure.com.

Copyright Business Wire 2010

If you liked this article you might like

Closing the Door on Abiomed

Capturing Profits on AIG

A Roundup of My Open Positions

Pumped Up About Abiomed Collar Play

Masimo's Stock Is a Great Buy Right Now